For the Inventor, By the Inventor

Enter assignee name

Asubio Pharma Co. Ltd.

USPTO Granted Patents = 19

% Expired Patents = 78.9

Forward Citations = 231

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Masayuki Yabuta (3 out of 10 patents)

Hirokazu Annoura (3 out of 18 patents)

Kazuhiro Ohsuye (3 out of 15 patents)

4. Hidekazu Inoue (2 out of 14 patents)

5. Hidenobu Murafuji (2 out of 6 patents)

6. Yasuhiro Hayashi (2 out of 17 patents)

7. Keijiro Sugimura (2 out of 3 patents)

8. Mayumi Furuya (2 out of 4 patents)

9. Kyoko Nakanishi (2 out of 11 patents)

10. Shigeki Tamura (2 out of 19 patents)

11. Hiroshi Yoshino (1 out of 5 patents)

12. Fumiyuki Hattori (1 out of 6 patents)

13. Ryuichi Morishita (1 out of 47 patents)

14. Kazuaki Okuno (1 out of 2 patents)

15. Yoshiharu Minamitake (1 out of 10 patents)

19 patents: Sort by Forward Citations

1. 8518893 - Medical compositions containing ghrelin (2013-08-27),

2. 8071307 - Method of detecting relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis (2011-12-06),

3. 7943624 - Pyridinylpyrazolopyrimidinone derivatives as PDE 7 inhibitors (2011-05-17),

4. 7816511 - Remedies for heart failure (2010-10-19),

5. 7807421 - Process for production of biopterin compound (2010-10-05),

6. 7713972 - Imidazotriazinone derivatives as PDE 7 (phosphodiesterase 7) inhibitors (2010-05-11),

7. 7642262 - Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same (2010-01-05),

8. 7618977 - Method of treating dermatitis comprising administering a chymase inhibitor (2009-11-17),

9. 7598228 - Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1 (2009-10-06),

10. 7582799 - Method for producing hydrazone derivatives (2009-09-01),

11. 7547529 - Methods for reducing the formation of by-products in the production of recombinant polypeptides (2009-06-16),

12. 7498344 - Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same (2009-03-03),

13. 7488738 - Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof (2009-02-10),

14. 7459551 - Method for preparing cyclic compounds (2008-12-02),

15. 7449177 - Remedy for pemphigoid (2008-11-11),

Company Overview

Asubio Pharma Co. Ltd., based in Tokyo, specializes in the research and development of innovative pharmaceuticals. The company focuses on creating therapeutic solutions that address unmet medical needs, particularly in the fields of oncology and autoimmune diseases. With a commitment to advancing healthcare, Asubio leverages cutting-edge technology and scientific expertise to develop novel drug candidates, aiming to improve patient outcomes and enhance the quality of life for individuals facing serious health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#1,381 in Tokyo

#3,041 in Japan

#32,693 in the World

Asubio Pharma Co. Ltd.

Forward Citations = 231

44 inventors:

Masayuki Yabuta (3 out of 10 patents)

Hirokazu Annoura (3 out of 18 patents)

Kazuhiro Ohsuye (3 out of 15 patents)

4. Hidekazu Inoue (2 out of 14 patents)

5. Hidenobu Murafuji (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Asubio Pharma Co. Ltd.. Retrieved from https://idiyas.com/company/asubio-pharma-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…